Julie Kolwelter
Erlangen, BY, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
Short- and mid-term effects of empagliflozin on sodium balance and fluid regulation in chronic heart failure.
Journal: European journal of heart failure
Published: July 11, 2025
PCSK-9-inhibitor therapy improves endothelial function in high-risk patients with cardiovascular disease.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: July 01, 2024
Multicenter International Study of the Consensus Immunoscore for the Prediction of Relapse and Survival in Early-Stage Colon Cancer.
Journal: Cancers
Published: October 27, 2022
The SGLT2 inhibitor empagliflozin reduces tissue sodium content in patients with chronic heart failure: results from a placebo-controlled randomised trial.
Journal: Clinical research in cardiology : official journal of the German Cardiac Society
Published: September 03, 2022
Clinical Performance of the Consensus Immunoscore in Colon Cancer in the Asian Population from the Multicenter International SITC Study.
Journal: Cancers
Published: August 03, 2022
Is vascular remodelling in patients with chronic heart failure exaggerated?
Journal: ESC heart failure
Published: June 02, 2022
Change of renal function after short-term use of cardioprotective agents in patients with type 2 diabetes is not accurately assessed by the change of estimated glomerular filtration rate: an observational study.
Journal: Diabetology & metabolic syndrome
Published: May 01, 2022
Angiotensin pathways under therapy with empagliflozin in patients with chronic heart failure.
Journal: ESC heart failure
Published: February 17, 2022
Effects of the sodium-glucose cotransporter 2 inhibitor empagliflozin on vascular function in patients with chronic heart failure.
Journal: ESC heart failure
Published: August 15, 2021
Effect of empagliflozin on ketone bodies in patients with stable chronic heart failure.
Journal: Cardiovascular diabetology
Published: August 08, 2021
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine.
Journal: Cardiovascular diabetology
Published: June 04, 2021
Dependency of flow-mediated vasodilatation from basal nitric oxide activity.
Journal: Clinical physiology and functional imaging
Published: December 30, 2020
Last Updated: 09/26/2026